Esper G. Kallas

Research.com Recognitions

• 2021 - Distinguished International Fellow of the American Society of Tropical Medicine and Hygiene (ASTMH)

Overview

Best Publications

• Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

  Robert M. Grant;Javier R. Lama;Peter L. Anderson;Vanessa McMahan

  6084
  Citations

• Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study

  Robert M. Grant;Robert M. Grant;Robert M. Grant;Peter L. Anderson;Vanessa McMahan;Albert Liu

  1375
  Citations

• Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

  Peter L. Anderson;David V. Glidden;Albert Liu;Susan Buchbinder

  1147
  Citations

• Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

  Raphael J Landovitz;Deborah Donnell;Meredith E Clement;Brett Hanscom

  781
  Citations

• Circulating Follicular Helper–Like T Cells in Systemic Lupus Erythematosus: Association With Disease Activity

  Jin Young Choi;John Hsi En Ho;Sandra G. Pasoto;Viviane Bunin

  346
  Citations

• Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans.

  David I Watkins;Dennis R Burton;Esper G Kallas;John P Moore

  335
  Citations

• HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial

  Madeline B Deutsch;David V Glidden;Jae Sevelius;Joanne Keatley

  310
  Citations

• Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.

  Ricardo Palacios;Elizabeth González Patiño;Roberta de Oliveira Piorelli;Monica Tilli Reis Pessoa Conde

  298
  Citations

• No Evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis

  Julia L. Marcus;David V. Glidden;Kenneth H. Mayer;Albert Y. Liu

  292
  Citations

• International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials

  T. Christopher Mast;Lisa Kierstead;Swati B. Gupta;Alexander A. Nikas

  266
  Citations

• Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study

  Beatriz Grinsztejn;Brenda Hoagland;Ronaldo I Moreira;Esper G Kallas

  219
  Citations

• Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.

  Alba Grifoni;John Pham;John Sidney;Patrick H O'Rourke

  206
  Citations

• Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial.

  Marc M. Solomon;Kenneth H. Mayer;Kenneth H. Mayer;David V. Glidden;Albert Y. Liu

  205
  Citations

• Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study

  Palacios R;Batista Ap;Albuquerque Csn;Patiño Eg

  198
  Citations

• Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock.

  Paulo Sergio Martins;Esper Georges Kallas;Miguel Cendoroglo Neto;Maria Aparecida Dalboni

  196
  Citations

• Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial.

  Ana C Medeiros-Ribeiro;Nadia E Aikawa;Carla G S Saad;Emily F N Yuki

  192
  Citations

• Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis.

  Marc M. Solomon;Javier R. Lama;David V. Glidden;Kathleen Mulligan

  186
  Citations

• Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal.

  Fatema A. Legrand;Douglas F. Nixon;Christopher P. Loo;Erika Ono

  181
  Citations

• QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans

  Thomas G. Evans;M.Juliana McElrath;Tom Matthews;David Montefiori

  174
  Citations

• Differential Persistence of Transmitted HIV-1 Drug Resistance Mutation Classes

  Vivek Jain;Maria C. Sucupira;Peter Bacchetti;Wendy Hartogensis

  172
  Citations

• Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository

  Reshma Kassanjee;Reshma Kassanjee;Christopher D. Pilcher;Sheila M. Keating;Shelley N. Facente

  168
  Citations

• Genealogical evidence for positive selection in the nef gene of HIV-1.

  Paolo M. de A. Zanotto;Esper G. Kallas;Robson F. de Souza;Edward C. Holmes

  160
  Citations

• High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project

  Brenda Hoagland;Ronaldo I. Moreira;Raquel B. De Boni;Esper G. Kallas

  157
  Citations

• IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID.

  Dominic Paquin-Proulx;Bianca A. N. Santos;Karina I. Carvalho;Myrthes Toledo-Barros

  154
  Citations

• Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease.

  Denise do Socorro da Silva Rodrigues;Eduardo Alexandrino Servolo de Medeiros;Lily Yin Weckx;W. Bonnez

  141
  Citations

• Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network.

  Matthew T. Aliota;Leda Bassit;Shelton S. Bradrick;Bryan Cox

  134
  Citations

• Human CD8+ T-Cell Responses Against the 4 Dengue Virus Serotypes Are Associated With Distinct Patterns of Protein Targets

  Daniela Weiskopf;Cristhiam Cerpas;Michael A. Angelo;Derek J. Bangs

  124
  Citations